Correction to Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970–99: a report from the Childhood Cancer Survivor Study cohort (The Lancet Oncology (2018) 19(12) (1590–1601), (S1470204518305370)(10.1016/S1470-2045(18)30537-0));Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970–99: a report from the Childhood Cancer Survivor Study cohort

The Lancet Oncology

Volumn 19, Issue 12, 2018, Pages 1590-1601

  Gibson, Todd M ^a   Mostoufi Moab, Sogol ^b   Stratton, Kayla L ^c   Leisenring, Wendy M ^c   Barnea, Dana ^d   Chow, Eric J ^c   Donaldson, Sarah S ^e   Howell, Rebecca M ^f   Hudson, Melissa M ^a   Mahajan, Anita ^g   Nathan, Paul C ^h   Ness, Kirsten K ^a   Sklar, Charles A ⁱ   Tonorezos, Emily S ⁱ   Weldon, Christopher B ^j   Wells, Elizabeth M ^k   Yasui, Yutaka ^a   Armstrong, Gregory T ^a   Robison, Leslie L ^a   Oeffinger, Kevin C ^l  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c USA   (United States)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g MAYO CLINIC   (United States)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^l DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; EPIPODOPHYLLOTOXIN; PLATINUM COMPLEX; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; ASTROCYTOMA; BONE TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM CANCER; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CHRONIC DISEASE; COHORT ANALYSIS; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HAZARD RATIO; HEARING IMPAIRMENT; HODGKIN DISEASE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MIDDLE AGED; MUSCULOSKELETAL DISEASE; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; NONHODGKIN LYMPHOMA; NORTH AMERICA; OSTEOSARCOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK ASSESSMENT; SIBLING; SOFT TISSUE SARCOMA; YOUNG ADULT; ADOLESCENT; AGE; CANADA; CHILD; HEALTH STATUS; INFANT; NEOPLASM; NEWBORN; ONSET AGE; PRESCHOOL CHILD; RADIOTHERAPY; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; TRENDS; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; ANTINEOPLASTIC AGENTS; CANADA; CANCER SURVIVORS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HEALTH STATUS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 85059305675     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(18)30928-8     Document Type: Erratum

References (30)

1. Robison, LL, Hudson, MM, Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer 14 (2014), 61–70.
2. SEER Cancer Statistics Review (CSR). 1975-2014, National Cancer Institute, Bethesda, MD http://seer.cancer.gov/csr/1975_2014. (Accessed 17 June 2018)
3. Geenen, MM, Cardous-Ubbink, MC, Kremer, LCM, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297 (2007), 2705–2715.
4. Frobisher, C, Glaser, A, Levitt, GA, et al. Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up. Br J Cancer 117 (2017), 1723–1731.
5. Armstrong, GT, Kawashima, T, Leisenring, W, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 32 (2014), 1218–1227.
6. Hudson, MM, Ness, KK, Gurney, JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309 (2013), 2371–2381.
7. Green, DM, Kun, LE, Matthay, KK, et al. Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors. Pediatr Blood Cancer 60 (2013), 1083–1094.
8. Hudson, MM, Neglia, JP, Woods, WG, et al. Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr Blood Cancer 58 (2012), 334–343.
9. Metzger, ML, Weinstein, HJ, Hudson, MM, et al. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA 307 (2012), 2609–2616.
10. Pui, CH, Campana, D, Pei, D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360 (2009), 2730–2741.
11. Armstrong, GT, Chen, Y, Yasui, Y, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med 374 (2016), 833–842.
12. Fidler, MM, Reulen, RC, Winter, DL, et al. Long term cause specific mortality among 34489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ, 354, 2016, i4351.
13. Garwicz, S, Anderson, H, Olsen, JH, et al. Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades–experience from the Nordic countries. Int J Cancer 131 (2012), 1659–1666.
14. Ness, KK, Hudson, MM, Jones, KE, et al. Effect of temporal changes in therapeutic exposure on self-reported health status in childhood cancer survivors. Ann Intern Med 166 (2017), 89–98.
15. Leisenring, WM, Mertens, AC, Armstrong, GT, et al. Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study. J Clin Oncol 27 (2009), 2319–2327.
16. Robison, LL, Armstrong, GT, Boice, JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 27 (2009), 2308–2318.
17. Stovall, M, Weathers, R, Kasper, C, et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res 166 (2006), 141–157.
18. Mulrooney, DA, Yeazel, MW, Kawashima, T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ, 339, 2009, b4606.
19. Green, DM, Nolan, VG, Goodman, PJ, et al. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 61 (2014), 53–67.
20. Oeffinger, KC, Mertens, AC, Sklar, CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355 (2006), 1572–1582.
21. Zou, G, A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159 (2004), 702–706.
22. Baron, RM, Kenny, DA, The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51 (1986), 1173–1182.
23. MacKinnon, DP, Fairchild, AJ, Fritz, MS, Mediation analysis. Annu Rev Psychol 58 (2007), 593–614.
24. Turcotte, LM, Liu, Q, Yasui, Y, et al. Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015. JAMA 317 (2017), 814–824.
25. Evans, AR, Brand, W, de Lorimier, A, et al. Results in children with local and regional neuroblastoma managed with and without vincristine, cyclophosphamide, and imidazolecarboxamide. A report from the Children's Cancer Study Group. Am J Clin Oncol 7 (1984), 3–7.
26. Maris, JM, Hogarty, MD, Bagatell, R, Cohn, SL, Neuroblastoma. Lancet 369 (2007), 2106–2120.
27. Matthay, KK, Villablanca, JG, Seeger, RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341 (1999), 1165–1173.
28. Antal, Z, Sklar, CA, Gonadal function and fertility among survivors of childhood cancer. Endocrinol Metab Clin North Am 44 (2015), 739–749.
29. Grewal, S, Merchant, T, Reymond, R, McInerney, M, Hodge, C, Shearer, P, Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group. Pediatrics 125 (2010), e938–e950.
30. Phillips, SM, Padgett, LS, Leisenring, WM, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev 24 (2015), 653–663.